Current medical research and literature may be overemphasizing the role that hospital volume plays in patient outcomes, according to a study co-authored by health economics fellow Vivian Ho.
Woohyeon Kim, Stephen Wolff, Vivian HoApril 15, 2016
Health care providers add multiple processes to the care of complex cancer patients, believing they prevent and/or ameliorate complications. However, the relationship between these processes, complication remediation, and expenditures is unknown.
Marah Short, Vivian Ho, Thomas AloiaSeptember 22, 2015
This study aimed to develop a systematic approach to classifying childhood cancer-related admissions in administrative data into categories that reflected clinical practice and predicted resource use.
Data on revenues by payer type are used to identify the determinants of rising hospital prices in Texas between 2000 and 2007. By Vivian Ho, Jerome Dugan and Meei-Hsiang Ku-Goto.
Every patient with cancer or another life-threatening disease wants the most effective treatment, but drug prices have become staggering. What determines the escalating prices of cancer drugs?
Donald Light, Hagop M. KantarjianSeptember 3, 2013
For both generic and patented cancer drugs, the free-market economy has not worked well. Solutions are needed to maintain reasonable drug prices that allow for corporate profits and are affordable to patients and to the U.S. health care system.
Hagop M. Kantarjian, Leonard A. ZwellingAugust 26, 2013
In a genuine effort to protect patients from adverse events, regulatory burdens and research rigidity in clinical trials have increased to a point at which such protection is outweighing the benefits, and actually harming patients who are unable to be involved in clinical trials.
Hagop M. Kantarjian, David J. Stewart, Leonard A. ZwellingJune 6, 2013
Allowing the producer-dominated market to set drug prices has spiraled the cost of cancer drugs out of control. Drug pricing can be reduced while preserving the profit-making incentive, by linking price to a true measure of quality: preservation and meaningful prolongation of life.
Altering the Medicare policy on injectable drugs is one way to reduce Medicare expenditures. Allowing self-administration will also free up hospital and clinic capacity for other patients.